A randomized trial of mifepristone in combination with misoprostol administered sublingually or vaginally for medical abortion at 13–20 weeks gestation

By Hamoda Haitham   Ashok Premila W.   Flett Gillian M.M.   Templeton Allan  

Human Reproduction, Vol. 20, Iss. 8, 2005-08 ,pp. : 2348-2354

Oxford University Press

Access to resources Recommend Favorite

A randomized double-blind placebo-controlled study to assess the effect of oral contraceptive pills on the outcome of medical abortion with mifepristone and misoprostol

By Tang OS  

Human Reproduction, Vol. 14, Iss. 3, 1999-03 ,pp. : 722-725

Oxford University Press

Access to resources Recommend Favorite

Misoprostol for cervical ripening in non-pregnant women: a randomized double-blind controlled trial of oral versus vaginal regimens

By Choksuchat C.   Cheewadhanaraks S.   Getpook C.   Wootipoom V.   Dhanavoravibul K.  

Human Reproduction, Vol. 21, Iss. 8, 2006-08 ,pp. : 2167-2170

Oxford University Press

Access to resources Recommend Favorite

A prospective randomized, double-blinded, placebo-controlled trial comparing mifepristone and vaginal misoprostol to vaginal misoprostol alone for elective termination of early pregnancy

By Jain John K.  

Human Reproduction, Vol. 17, Iss. 6, 2002-06 ,pp. : 1477-1482

Oxford University Press

Access to resources Recommend Favorite

A prospective, randomized, placebo‐controlled trial on the use of mifepristone with sublingual or vaginal misoprostol for medical abortions of less than 9 weeks gestation

By Tang Oi Shan   Chan Carina C.W.   Ng Ernest H.Y.   Lee Sharon W.H.   Ho Pak Chung  

Human Reproduction, Vol. 18, Iss. 11, 2003-11 ,pp. : 2315-2318

Oxford University Press

Access to resources Recommend Favorite